National Minority Donor Awareness Month 2026: Make Access, Voice, and Follow-Through Visible

National Minority Donor Awareness Month can prompt a useful public conversation about organ, eye, tissue, marrow, and blood stem cell donation. For healthcare executives, however, the observance should also prompt a systems question: after awareness increases, can people find trustworthy information, ask questions in a language and setting that works for them, record a voluntary decision, reach transplant evaluation when clinically appropriate, complete complex requirements, receive a fair matching process, and remain supported when ownership moves between organizations?

Those are related but distinct routes. A public donor-registration pathway is not the same as a living-donor evaluation. Deceased-donation authorization is not the same as a transplant-center referral. Marrow registry matching is not the same as solid-organ allocation. Tissue and eye donation have their own eligibility and recovery processes. A respectful campaign can acknowledge the shared values of informed choice and community benefit while clearly explaining that eligibility, timing, compatibility, legal authority, clinical assessment, and operational roles differ.

Executives should resist reducing success to impressions, social engagement, event attendance, brochure distribution, or new registrations. Those measures can describe reach, but they do not show whether information was understood, questions were answered, referrals were accepted, evaluations began, financial and logistical barriers were addressed, handoffs were acknowledged, or people experienced the process as trustworthy. The management task is to make the pathway observable without turning personal decisions into performance pressure.

A 2025 kidney-transplant cohort of 15,673 referred adults in the Ohio River Valley illustrates why the entry-to-evaluation transition deserves scrutiny. In adjusted analyses, Black patients had a lower likelihood of starting evaluation than White patients, and patients with Medicaid or Medicare had a lower likelihood than those with employer insurance. Among people who began evaluation, differences in waitlisting also remained for Black patients and those with public insurance.³ These observational findings do not explain any individual's experience and do not establish a single cause. They do show that a referral count alone is an incomplete access measure.

A scoping review reached a similar system-level conclusion across 14 U.S. studies. White men generally had the greatest access at multiple points in the kidney-transplant pathway, while women from racial and ethnic minority groups often had the lowest access, particularly for living donor kidney transplantation. The pattern was not uniform across every study or stage.⁸ Leaders therefore need intersectional review, adequate denominators, locally governed data, and direct listening. A broad category can hide different experiences by gender, insurance, language, geography, disability, age, caregiver support, or stage of care.

Trust is not a demographic trait and should not be framed as a community deficit. It is shaped by current and historical experiences, the behavior of institutions, the clarity of information, whether questions are welcomed, whether a person sees consistent follow-through, and whether care remains respectful after a decision. Leaders can influence those conditions by making commitments observable: use plain language, disclose uncertainty, explain roles, provide qualified language access, protect privacy, separate care from donation pressure, and document what happens after concerns are raised.

A 2026 cross-sectional study of 416 African American patients undergoing kidney-transplant evaluation found that favorable attitudes toward living donor kidney transplantation and trust in kidney doctors were associated with intent to discuss living donation. Trust in hospitals and the health system and reported interactions were not significant in that statistical model.¹ The findings do not prove that increasing trust will cause a discussion or donation. They suggest that the relationship with the clinical team and the quality of the living-donation conversation deserve attention during evaluation.

A 2025 U.S. survey of 201 Black and White adults found that donor status was related to trust in doctors and trust in care for one's racial group, but not to religious service attendance or religious norms. Black participants reported lower trust in care for their racial group, while the difference in trust in doctors was not significant.⁶ A modest cross-sectional survey cannot represent every faith tradition, racial group, or local community. It does challenge a common shortcut: leaders should not assume that religiosity explains a person's decision or substitute a generalized cultural narrative for a direct, respectful conversation.

Community-based programs can strengthen knowledge and confidence, but outreach exposure does not guarantee registration. In a 2023 nonrandomized program, 40 promotoras received web-based education and communication-skills support. Their communication confidence increased, while knowledge and support measures did not change significantly. Twenty-five promotoras then held 52 discussions with 375 attendees; reported knowledge of registration steps and belief that registration was easy increased, and 21 attendees submitted a registration.¹³ The study used participants as their own controls and should be treated as preliminary program evidence.

A randomized trial involving 1,353 participants in Black-owned barbershops found that targeted and tailored videos did not differentially increase organ-donor registration compared with a generic video. The approaches did increase brochure taking and readiness or willingness stage.¹⁶ This distinction is important. Awareness, information seeking, willingness to discuss, documented choice, and completed registration are separate outcomes. A single message may move one stage without moving another.

Design engagement as a continuing service rather than a one-time persuasion event. Give community partners a direct route for unanswered questions, updates when policies or service capacity change, a way to report harmful or confusing language, and evidence that feedback led to action. Compensate community expertise when appropriate. Do not ask trusted messengers to absorb institutional failures or to promise access they cannot control.

Communication quality is not achieved by translating a brochure after the pathway has been designed. It requires qualified language access, role-specific training, timing standards, understandable explanations, space for questions, documentation of preferences, and feedback from the people receiving the communication. It also requires candor about uncertainty. A family authorization conversation, a living-donor discussion, a marrow-registry recruitment event, and a transplant evaluation do not have the same purpose or emotional context.

A 2025 review of cross-cultural organ-donation requests found only nine eligible studies after screening 427 abstracts and 46 full texts. Across this small international literature, foreign birth, language barriers, and high religiosity were associated with lower approach or consent in included studies. Interpreter use showed a negative association in some reports, family satisfaction was lower in some settings, and racially discordant request communication was rated less favorably.⁴ Those associations should not be interpreted to mean that interpreters cause lower consent or that racial concordance guarantees trust. Interpreter use can mark a more complex communication context. The limited evidence base supports better design and study, not a demographic script.

Qualitative evidence can help leaders see operational conditions that are hard to capture in a rate. In Ontario focus groups with 10 organ and tissue donation coordinators, participants described timing and provider ambivalence as barriers and discussed value-positive language and education as possible strategies.¹⁸ The study reflects a small group and a specific legal context. Its practical value is the reminder that the requester does not operate alone. The behavior of referring and treating teams can shape whether the conversation is timely, coordinated, and supported.

The fishbone is deliberately qualitative. It should be completed with people who have used the local pathway, donor families, transplant candidates and recipients, living donors and candidates, community partners, coordinators, language-access professionals, social workers, clinicians, data stewards, and frontline staff. The group should ask which conditions are present locally, how they are known, what remains uncertain, and who has authority to act.

A 2022 survey of 121 Asian American physicians in Queens found that donor registration was associated with family discussion, knowledge that HLA did not need to match, and advising patients to register. Only 22% of respondents reported being registered.¹⁵ The sample was small and the confidence intervals were wide. The study does not support assuming that physician knowledge automatically becomes personal action. It does reinforce that accurate information, family conversation, and clinician behavior can be separate targets for education.

Communication governance should include a content owner, clinical and legal review as appropriate, version control, expiration dates, interpreter and translation workflows, accessibility checks, staff preparation, escalation for unanswered questions, and a rapid correction mechanism. Train staff to say what is known, what is not known, and who can answer the next question. A translated message without an accessible service route is an incomplete intervention.

A useful measurement system separates awareness, experience, access, process reliability, clinical appropriateness, and outcome. It does not reward consent, registration, or living donation as if they were staff-controlled outputs. It asks whether people received a consistent opportunity to understand and choose, whether referrals and questions reached the correct owner, whether practical support was available, whether matching and alternatives were pursued appropriately, and whether exceptions led to learning.

In England, a 2024 mixed-methods study drew on 12 surveys with 19,011 respondents, quarterly surveys totaling 45,439 people around a soft opt-out law change, and 30 interviews. General support remained near 80% but was lower among ethnic-minority respondents; awareness of the law averaged 58% overall and 31% among minority ethnic respondents. The law change was not associated with a material shift in attitudes or preferences, while interviews highlighted family, community, and misinformation.¹¹ Legal or policy change does not remove the need for understandable communication and family engagement.

Measurement should therefore include comprehension and experience, not merely exposure. It should also examine who is missing. A denominator based only on completed evaluations cannot show people who did not start. A family-experience survey sent only after authorization misses people who declined or were never approached. A registry-recruitment count does not reveal whether recruits completed typing, remained contactable, or were available when matched. Each dashboard should state its inclusion rules and blind spots.

Build the scorecard around decisions, not decoration

Start with a small set of signals that can change a management decision. Define numerator, denominator, exclusions, source, owner, cadence, missingness, stratification rules, and escalation before publishing a rate. Pair each outcome signal with a process and balancing measure. For example, a faster referral acknowledgment should be reviewed with wrong-route redirects, repeat contacts, staff workload, interpreter availability, and patient experience. A larger number of approaches should be reviewed with eligibility consistency, timing, family experience, and staff adherence to autonomy protections.

Use statistical and ethical caution with small groups. Suppress or combine cells when privacy or stability requires it, but do not let suppression erase a recurring concern. Protected case review and qualitative listening may be safer and more informative than a public percentage. When a gap appears, verify the source data, examine the process, listen to affected people, and test a plausible change. Do not assign cause from a dashboard alone.